oston Scientific. "As we continue to expand our portfolio, our team is inspired to deliver meaningful innovation to more patients globally."Worldwide sales for the second quarter: Three Months EndedJune 30,% Changein millions
20132012As Reported BasisLess: Impact of Foreign CurrencyConstant Currency BasisInterventional Cardiology
5%Cardiovascular719745(4)%(21)(3)%(1)%Cardiac Rhythm Management
21%MedSurg5605286%(13)(3)%9%Subtotal Core Businesses1,7901,7980%(39)(2)%2%Divested Businesses
(38)%Worldwide Net Sales$1,809$1,828(1)%$(38)(2)%1%Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.
Sales growth rates that exclude the impact of changes in foreign currency exchange rates are not prepared in accordance with U.S. GAAP. An explanation of the company's use of these non-GAAP financial measures is included in the exhibits attached to this news release.
On a consolidated GAAP basis, net income for the second quarter of 2013 was $130 million, or earnings of $0.10 per share. These results included an intangible asset impairment charge, acquisition- and divestiture-related net credits, restructuring-related charges, and amortization expense, of $117 million (after-tax) or $0.08 per share. Adjusted net income for the second quarter of 2013, excluding these net charges, was $247 million, or $0.18 per share.
On a consolidated GA
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Related biology technology :1
|SOURCE Boston Scientific Corporation|
Copyright©2012 PR Newswire.
All rights reserved
. American Laboratory Trading Continues Steady Growth with Expansion in Boston2
. Affordable Scrum Training in Boston,MA by Conscires Agile Practices3
. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston4
. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA5
. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials6
. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center7
. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit8
. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.9
. Boston College researchers unique nanostructure produces novel plasmonic halos10
. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th11
. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration